| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Marcos Malumbres | Q37619339 |
| P2093 | author name string | María José Bueno | |
| P2860 | cites work | miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation | Q24655473 |
| Transcription-independent functions of MYC: regulation of translation and DNA replication | Q37242438 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 592-601 | |
| P577 | publication date | 2011-02-18 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | MicroRNAs and the cell cycle | |
| P478 | volume | 1812 |
| Q36769475 | A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q38238683 | Acute kidney injury: a paradigm for miRNA regulation of the cell cycle. |
| Q98386176 | Advances in oligonucleotide drug delivery |
| Q38809473 | Altered miRNA expression in aniline-mediated cell cycle progression in rat spleen. |
| Q39392478 | Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells |
| Q58070020 | Association of miR-145 With Statin-Induced Skeletal Muscle Toxicity in Human Rhabdomyosarcoma RD Cells |
| Q92590233 | Bi-modal reprogramming of cell cycle by MiRNA-4673 amplifies human neurogenic capacity |
| Q64083069 | Biclustering analysis of transcriptome big data identifies condition-specific microRNA targets |
| Q40497578 | CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest. |
| Q35627570 | CREB and leukemogenesis |
| Q36695607 | CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade. |
| Q43123105 | Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression |
| Q52726443 | Cell Cycle Regulation of Stem Cells by MicroRNAs. |
| Q38123666 | Cell cycle regulation by long non-coding RNAs |
| Q37543840 | Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children |
| Q51750884 | Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. |
| Q39119180 | Clinic significance of microRNA-99a expression in human lung adenocarcinoma |
| Q36746944 | Comparison of non-coding RNAs in human and canine cancer |
| Q36329527 | Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study |
| Q33576862 | Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner |
| Q37625624 | Dicer, a new regulator of pluripotency exit and LINE-1 elements in mouse embryonic stem cells. |
| Q33860217 | Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics |
| Q48285209 | Differential expression of miRNAs with metabolic implications in hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus |
| Q35698576 | Disorder of G2-M Checkpoint Control in Aniline-Induced Cell Proliferation in Rat Spleen |
| Q35924242 | Dissecting genetics of cutaneous miRNA in a mouse model of an autoimmune blistering disease |
| Q42657259 | Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers |
| Q37076251 | E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation |
| Q38985933 | Epigenetic regulation of hepatic stellate cell activation and liver fibrosis |
| Q51733913 | Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis? |
| Q38764098 | Exploiting microRNAs As Cancer Therapeutics |
| Q54339183 | Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. |
| Q41956798 | Expression of senescence-associated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction |
| Q36032827 | Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression |
| Q24490032 | Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection |
| Q38748516 | Gene expression of miRNA-138 and cyclin D1 in oral lichen planus. |
| Q34645999 | General aspects of colorectal cancer |
| Q34203950 | Genetic alterations in microRNAs in medulloblastomas |
| Q34268565 | Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways |
| Q47999229 | Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence |
| Q48167948 | Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs |
| Q36210880 | Growth inhibition by miR-519 via multiple p21-inducing pathways |
| Q28571470 | Identification and characterization of FGF2-dependent mRNA: microRNA networks during lens fiber cell differentiation |
| Q34858444 | Identification and characterization of microRNAs in pearl oyster Pinctada martensii by Solexa deep sequencing |
| Q35669176 | Identification of cis-Regulatory Elements in the dmyc Gene of Drosophila Melanogaster |
| Q35560735 | Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway |
| Q90654712 | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
| Q28597874 | Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data |
| Q37983889 | Involvement of miRNA in erythroid differentiation |
| Q38845763 | Life sciences today and tomorrow: emerging biotechnologies |
| Q38431483 | Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer. |
| Q26785379 | MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q89865978 | MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression |
| Q37746045 | MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. |
| Q42144209 | MiR-371-373 cluster acts as a tumor-suppressor-miR and promotes cell cycle arrest in unrestricted somatic stem cells |
| Q57148184 | MiR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells |
| Q38963021 | MicroRNA 130b enhances drug resistance in human ovarian cancer cells |
| Q38704488 | MicroRNA Regulation of Acute Lung Injury and Acute Respiratory Distress Syndrome |
| Q26768416 | MicroRNA aberrations: An emerging field for gallbladder cancer management |
| Q53137197 | MicroRNA and cancer. |
| Q37034049 | MicroRNA expression and its association with DNA repair in preimplantation embryos |
| Q41053612 | MicroRNA inhibition fine-tunes and provides robustness to the restriction point switch of the cell cycle |
| Q39171984 | MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a |
| Q42590406 | MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice |
| Q34354797 | MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes |
| Q49670720 | MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2. |
| Q39281229 | MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell |
| Q34273664 | MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q91668818 | MicroRNAs - novel biomarkers for malignant pleural effusions |
| Q42256160 | MicroRNAs 106b and 222 Improve Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes via Pancreatic β-Cell Proliferation |
| Q38497875 | MicroRNAs and cell cycle of malignant glioma |
| Q38052928 | MicroRNAs as potential biomarkers of smoking-related diseases |
| Q38018097 | MicroRNAs as therapeutic targets and their potential applications in cancer therapy |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q33585094 | MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment |
| Q38767024 | Mir-221/222 are promising targets for innovative anticancer therapy. |
| Q35881967 | Mir-33 regulates cell proliferation and cell cycle progression. |
| Q92238135 | Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation |
| Q52715737 | Modeling-Based Investigation of the Effect of Noise in Cellular Systems. |
| Q47737123 | Modelling the propagation of a dynamical signature in gene expression mediated by the transport of extracellular microRNAs. |
| Q56999984 | Molecular Mechanism of Aniline Induced Spleen Toxicity and neuron toxicity in experimental rat exposure: A review |
| Q38066944 | More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma |
| Q91963392 | NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ |
| Q26824409 | Network calisthenics: control of E2F dynamics in cell cycle entry |
| Q36493809 | Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p |
| Q26778014 | Non-coding landscapes of colorectal cancer |
| Q38826069 | Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression. |
| Q37565996 | Nuclear microRNAs in normal hemopoiesis and cancer |
| Q35014565 | Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines |
| Q34768088 | Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer |
| Q52721513 | Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs. |
| Q26773479 | RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action |
| Q92609636 | RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome |
| Q52691327 | RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas. |
| Q30467210 | Regeneration of Hair Cells: Making Sense of All the Noise |
| Q39305402 | Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma |
| Q36318823 | Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells |
| Q33850064 | Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators |
| Q35083489 | RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression |
| Q34612994 | Robustness and backbone motif of a cancer network regulated by miR-17-92 cluster during the G1/S transition. |
| Q98224804 | Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression |
| Q64102260 | Role of miRNA in the Transmission of Metabolic Diseases Associated With Paternal Diet-Induced Obesity |
| Q37707666 | Roles of mitochondrial transcription factor A and microRNA‑590‑3p in the development of colon cancer |
| Q58748636 | Sex-specific associations between telomere length and candidate miRNA expression in placenta |
| Q38627793 | Small Noncoding RNA Expression During Extreme Anoxia Tolerance of Annual Killifish (Austrofundulus limnaeus) Embryos. |
| Q98386355 | Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study |
| Q38954637 | Study of apoptosis-related interactions in colorectal cancer |
| Q40059808 | Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy. |
| Q38913559 | The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition |
| Q91752429 | The broken cycle: E2F dysfunction in cancer |
| Q54941919 | The impact of Mir-9 regulation in normal and malignant hematopoiesis. |
| Q36194939 | The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer |
| Q38283518 | The mystery of let-7d - a small RNA with great power |
| Q38152293 | The network of P-glycoprotein and microRNAs interactions |
| Q44763194 | The role of CCND1 alterations during the progression of cutaneous malignant melanoma |
| Q58754045 | The role of gene sculptor microRNAs in human precancerous lesions |
| Q38289575 | The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma |
| Q37996436 | The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. |
| Q36310222 | The role, mechanism and potentially novel biomarker of microRNA-17-92 cluster in macrosomia |
| Q36721273 | The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma |
| Q53275343 | Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal. |
| Q28082114 | Transcriptional control of mitosis: deregulation and cancer |
| Q37110591 | Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy |
| Q28081287 | Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia |
| Q37720029 | Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma |
| Q47829208 | Two way controls of apoptotic regulators consign DmArgonaute-1 a better clasp on it. |
| Q26801907 | Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease |
| Q30969414 | Validating reference microRNAs for normalizing qRT-PCR data in bovine oocytes and preimplantation embryos |
| Q34335185 | XB130, a new adaptor protein, regulates expression of tumor suppressive microRNAs in cancer cells. |
| Q26851373 | c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies |
| Q36609152 | miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression |
| Q41865341 | miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma |
| Q34745553 | miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines |
| Q55394609 | miRNA involvement in cell cycle regulation in colorectal cancer cases. |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q34286618 | miRNAs and cancer: an epigenetics view |
| Q34635855 | miRNAs versus oncogenes: the power of social networking |
| Q34150950 | microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells |
| Q35078061 | microRNA as a potential vector for the propagation of robustness in protein expression and oscillatory dynamics within a ceRNA network |
| Q92657881 | microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma |
| Q47375547 | microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview |
| Q48343149 | p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs |
Search more.